Masimo Corporation (NASDAQ:MASI) Receives $193.60 Consensus PT from Analysts

Key Points

• Masimo Corporation's shares receive a consensus recommendation of "Buy" from seven analysts, with an average one-year target price of $193.60.
• Insider transactions include Director William R. Jellison purchasing 3,000 shares at an average price of $145.98, increasing his ownership by 167.60%.
• The company reported $1.33 EPS for the last quarter, exceeding estimates, with a revenue of $370.90 million, up 7.7% from the previous year.

Shares of Masimo Corporation (NASDAQ:MASI - Get Free Report) have been assigned an average recommendation of "Buy" from the seven brokerages that are covering the stock, MarketBeat Ratings reports. One investment analyst has rated the stock with a hold rating, five have assigned a buy rating and one has assigned a strong buy rating to the company. The average 12-month target price among brokerages that have issued ratings on the stock in the last year is $194.60.

A number of research firms have weighed in on MASI. BTIG Research reissued a "buy" rating and set a $198.00 target price on shares of Masimo in a research report on Thursday. Piper Sandler boosted their target price on shares of Masimo from $200.00 to $210.00 and gave the stock an "overweight" rating in a research report on Wednesday, August 6th. Zacks Research raised shares of Masimo from a "hold" rating to a "strong-buy" rating in a research report on Wednesday, September 3rd. Finally, Wall Street Zen downgraded shares of Masimo from a "buy" rating to a "hold" rating in a report on Friday, May 30th.

Masimo Stock Up 0.8%

Shares of MASI stock traded up $1.23 on Monday, hitting $147.44. The company's stock had a trading volume of 699,217 shares, compared to its average volume of 574,415. The stock has a market capitalization of $8.01 billion, a price-to-earnings ratio of -17.31 and a beta of 1.23. The company has a debt-to-equity ratio of 0.57, a current ratio of 2.14 and a quick ratio of 1.61. Masimo has a fifty-two week low of $111.03 and a fifty-two week high of $194.88. The firm's fifty day moving average price is $152.26 and its 200-day moving average price is $159.49.

Masimo (NASDAQ:MASI - Get Free Report) last released its earnings results on Tuesday, August 5th. The medical equipment provider reported $1.33 earnings per share for the quarter, topping analysts' consensus estimates of $1.22 by $0.11. The firm had revenue of $370.90 million during the quarter, compared to analyst estimates of $368.65 million. Masimo had a negative net margin of 24.85% and a positive return on equity of 26.54%. The business's revenue was up 7.7% on a year-over-year basis. During the same quarter in the previous year, the business earned $0.86 EPS. Research analysts anticipate that Masimo will post 4.1 EPS for the current year.

Insider Activity at Masimo

In related news, Director William R. Jellison acquired 3,000 shares of the business's stock in a transaction dated Monday, August 11th. The stock was acquired at an average price of $145.98 per share, with a total value of $437,940.00. Following the completion of the transaction, the director owned 4,790 shares of the company's stock, valued at approximately $699,244.20. This represents a 167.60% increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is accessible through the SEC website. Corporate insiders own 9.70% of the company's stock.

Institutional Inflows and Outflows

A number of large investors have recently made changes to their positions in the stock. Twin Tree Management LP bought a new stake in Masimo in the first quarter valued at about $29,000. MAI Capital Management increased its stake in Masimo by 176.7% in the second quarter. MAI Capital Management now owns 202 shares of the medical equipment provider's stock valued at $34,000 after acquiring an additional 129 shares during the period. Farther Finance Advisors LLC increased its stake in Masimo by 128.9% in the first quarter. Farther Finance Advisors LLC now owns 206 shares of the medical equipment provider's stock valued at $35,000 after acquiring an additional 116 shares during the period. Hilltop National Bank bought a new stake in Masimo in the second quarter valued at about $37,000. Finally, Anderson Financial Strategies LLC bought a new stake in Masimo in the first quarter valued at about $49,000. Institutional investors and hedge funds own 85.96% of the company's stock.

Masimo Company Profile

Masimo Corporation develops, manufactures, and markets various patient monitoring technologies, and automation and connectivity solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of carboxyhemoglobin, methemoglobin, hemoglobin concentration, fractional arterial oxygen saturation, oxygen content, pleth variability index, rainbow pleth variability index, respiration rate from the pleth, and oxygen reserve index, as well as acoustic respiration monitoring, SedLine brain function monitoring, NomoLine capnography and gas monitoring, and regional oximetry.